Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Read more about Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Genomic features underlying meningioma sex-specificity. Read more about Genomic features underlying meningioma sex-specificity.
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report. Read more about Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report.
The TCR Repertoire: A Window Into Pediatric Brain Tumor Immunity. Read more about The TCR Repertoire: A Window Into Pediatric Brain Tumor Immunity.
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative. Read more about Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative.
Dual αVβ8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Glioma Immunity. Read more about Dual αVβ8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Glioma Immunity.
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4. Read more about A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4.
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Read more about Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.
Applications of Artificial Intelligence and Advanced Imaging in Pediatric Diffuse Midline Glioma. Read more about Applications of Artificial Intelligence and Advanced Imaging in Pediatric Diffuse Midline Glioma.
Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy. Read more about Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy.
